SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 1, 2026

ORKA

Oruka Therapeutics, Inc.
BEARISH
Impact 4/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $5.9M total
Actionable Insight ▼ Bearish

The CEO exercised deeply in-the-money options and sold nearly all the resulting shares in a single day, a pattern consistent with pre-planned 10b5-1 diversification rather than a bearish signal. However, the concentration on one date and involvement of both C-suite executives warrants monitoring the next 10-Q for any negative fundamental surprise. Given the $6.1B market cap and 0.10% magnitude, this is unlikely to move the stock meaningfully.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$91.63
T+0 close · Sep 1, 2026 · via day close
Latest settled
−9.10%
T+20 · $83.29 · next T+60 in 10d
Vs SPY
−8.77%
α at T+20
Latest observation
+32.41%
T+52 · FF3 residual α
  1. T+0 · Sep 2 $91.63entry
  2. T+1 · 3mo ago −0.70%α −1.75% · $90.99
  3. T+5 · 2mo ago +0.02%α +0.98% · $91.65
  4. T+20 · 7w ago −9.10%α −8.77% · $83.29
  5. T+52 · todayOpen
  6. T+60 · in 10d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Oruka Therapeutics CEO Lawrence Klein and COO Laura Sandler sold a combined $5.94M in open-market stock on September 1, 2026. While the CEO's sales are partly explained by cashless derivative exercises at $7.80 strike (pre-funded near 100% profit), the $5.84M CEO sale is large relative to market cap (0.1%). The net selling direction and C-suite participation merit attention, though the size is modest as a percentage of market cap (<0.1%), keeping the signal below the materiality threshold.

Key Financial Metrics

Direction
selling
Total Value
$5.9M
Insiders
2

Key Facts

  • CEO Lawrence Klein sold 75,000 shares total (6.6K + 4.8K + 63.6K) in open-market sales for ~$6.89M, all on 2026-09-01
  • CEO also exercised two derivative tranches: 75,000 shares at $7.80 ($585K exercise) and 75,000 shares at $0 (non-cash award)
  • COO Laura Sandler sold 5,000 shares total for ~$459K on 2026-09-01 after exercising 5,000 at $7.80 and 5,000 at $0
  • Combined open-market sales: CEO $6.89M + COO $459K = $7.35M total; net cluster value after derivative exercises: $5.94M
  • Derivative exercises were essentially cashless, sold most shares immediately to lock in $84+ per share profit
  • Total open-market sales of $7.35M represent ~0.12% of Oruka's $6.1B market cap
  • The cluster is concentrated in a single day (2026-09-01), suggesting coordinated execution of a pre-arranged plan

Financial Impact

CEO and COO insider sales totaling $5.94M net value on September 1, 2026, 0.10% of $6.1B market cap

insider ownershipliquidity

Risk Factors

  • Insider selling cluster concentrated on one date suggests potential vesting or window-driven sales, not necessarily informed bearish view
  • CEO sold 100% of exercised shares immediately, locking in profit, typical for option exercise patterns
  • No recent company disclosures (earnings, trial data, guidance) in the cross-filing context to connect the sales to fundamental news

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1788303680828

Track record

40 reports on ORKA

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 9h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 1, 2026